Paul F Elliott, MD | |
2010 Brookwood Medical Ctr Dr, Birmingham, AL 35209-6804 | |
(202) 989-1080 | |
(205) 989-1087 |
Full Name | Paul F Elliott |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Location | 2010 Brookwood Medical Ctr Dr, Birmingham, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053317271 | NPI | - | NPPES |
000010809 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | MD.9497 (Alabama) | Primary |
Entity Name | Anesthesiologists Associated Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851371850 PECOS PAC ID: 6204739519 Enrollment ID: O20040202000465 |
News Archive
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
When an infected tsetse fly bites humans or other mammals to feed on their blood, microscopic parasites (African trypanosomes) in the fly's saliva are transferred. The unfortunate recipient of the bite, once infected, often faces severe health consequences, even death.
Many public health experts feared the COVID-19 pandemic would cause an increase in suicidal behavior among U.S. military veterans, a group that already has high rates of depression and posttraumatic stress disorder and which experienced a 30% surge in suicides between 2010 and 2018.
People who leave hospital against their doctors' orders are more likely to be readmitted to hospital or die, according to a new study in CMAJ (Canadian Medical Association Journal).
Soligenix, Inc. (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has enrolled and treated all patients in the Phase 1 Study BDP-PCD-01; the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Paul F Elliott, MD 2151 Old Rocky Ridge Rd, Suite 106, Birmingham, AL 35216-6101 Ph: (205) 989-1080 | Paul F Elliott, MD 2010 Brookwood Medical Ctr Dr, Birmingham, AL 35209-6804 Ph: (202) 989-1080 |
News Archive
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.
When an infected tsetse fly bites humans or other mammals to feed on their blood, microscopic parasites (African trypanosomes) in the fly's saliva are transferred. The unfortunate recipient of the bite, once infected, often faces severe health consequences, even death.
Many public health experts feared the COVID-19 pandemic would cause an increase in suicidal behavior among U.S. military veterans, a group that already has high rates of depression and posttraumatic stress disorder and which experienced a 30% surge in suicides between 2010 and 2018.
People who leave hospital against their doctors' orders are more likely to be readmitted to hospital or die, according to a new study in CMAJ (Canadian Medical Association Journal).
Soligenix, Inc. (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has enrolled and treated all patients in the Phase 1 Study BDP-PCD-01; the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.
› Verified 9 days ago
Riaz Mohammed Karukappadath, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Dr. Victor E. Mendoza, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5130 Cyrus Cir, Birmingham, AL 35242 Phone: 205-981-0414 | |
Joshua Edward Smith, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Stacy Wade, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Bernis A Simmons, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 52 Medical Park Dr E, Suite 321, Birmingham, AL 35235 Phone: 205-838-3055 Fax: 205-838-3517 | |
George R. Wells Iii, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1201 11th Ave S, Birmingham, AL 35205 Phone: 205-930-7246 | |
Teddy W. Sartin, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1600 Carraway Blvd, Birmingham, AL 35234 Phone: 205-502-6817 Fax: 205-502-5152 |